Australian Business Forum helps Australian SMEs and businesses to understand the Chinese market and refine their China strategy. http://abf.events/ ABOUT THE PRESENTATION CEO of AusBiotech, Dr Anna Lavelle Presenting on how Australia leads for biotech companies in the Asia-Pacific region Industry currently employs over 45,000 Australians in high-value jobs, attracts >$1 billion a year in R&D investment and exports goods worth $3.5 billion a year

1. Fortune Forum Australian Summit 2015:
The Australian Biotechnology Landscape
25 November 2015
Dr Anna Lavelle, CEO, AusBiotech

2. AusBiotech
• AusBiotech is Australia’s industry organisation, working on behalf of
members for nearly 30 years to provide representation and services
to promote the global growth of Australian biotechnology.
• AusBiotech is a network of over 3,000 researchers, companies and
investors in the life sciences sector, working in therapeutics, medical
technology (devices and diagnostics), food technology and
agriculture.

3. AusBiotech programs
• National and stage government policy reform
• Investment Series – Australia, New York, San Francisco, Hong Kong,
London
• Over 70 events nationally / internationally per year
• Support for companies seeking to export, e.g. trade missions, China
Guide for Medical Devices
• Support for non-executive directors and CEOs of life science
companies, e.g. Life Sciences Reporting Guide and Guide for
Directors of Life Science Companies
• Regular information to the sector via journal, e-newsletter and
briefings.

4. AusBiotech programs
• Partnering with others to deliver:
– Industry mentors for 2nd and 3rd year graduate students, taking
top students from Australian universities
– International representation at conferences
– Australia/China Health Summit
– Influencing government policy, e.g. Medical Research Future
Fund, R&D tax incentive, Australian Innovation &
Manufacturing incentive, clinical trial reform.

5. Australia Biotech Invest 2015
• Held in Hong Kong, June 2015 (4th year running)
• In 2015:
– 230 delegates, including 123 investors
– 23 presenting companies from Australia, USA and
Singapore
– 55 international delegates from China, India, The
Netherlands, New Zealand, Singapore, South Korea, the
UK, and the United States

6. Australian biotechnology
• Industry currently employs over 45,000 Australians in high-
value jobs, attracts >$1 billion a year in R&D investment and
exports goods worth $3.5 billion a year.
• Australia is a leading location of biotechnology companies in
the Asia-pacific, with ~300 biotechs (>100 ASX listed) and
400 medtech companies.

7. How does Australia rate?
On an overall basis, the latest
Scientific American, Worldview Scorecard
2015 rated Australia # 4 globally in biotechnology for the
second consecutive year.
Measured by Intellectual Property protection, intensity,
enterprise support, workforce, policy & stability.

8. How does Australia rate?
Scientific American, Worldview Scorecard 2015
Adjusted for population
In global top three on six indicators:
#2 Best growth in biotech public markets
#2 Greatest public company revenues
#2 Most public companies
#2 Greatest public company market cap
#2 Most public company employees
#2 Best growth in biotech public markets

9. Capital raised by Australian companies
2007 - $ 943m
2008 - $ 183m 2014 – $458 million
2009 - $ 672m
2011 - $ 630m
2012 - $ 257m
2013 - $ 739m
Source: BioShares & Biotech Daily

10. R&D Tax Incentive
Biotech has been a big winner:
• 45% cash refundable component for companies with TO of
less than $20m
• 40% offset for companies with TO over $20m and under
$20b
• Capped at $100m claims

11. Patent Box
Aims to increase country competitiveness by spurring
firms to invest more in innovation, producing more
spill-over benefits, and also by providing a more
competitive corporate tax climate for increasingly
innovation-based firms.

12. Patent Box
Nations adopt patent box for two key reasons:
• Recognise that the process of innovation is subject to
multiple market failures, which limit spillover benefits.
• Recognise process of innovation is much more global and
need tax code to be more competitive.
• 10 countries have a version of patent box and the USA is
currently considering one.